Zurich Cantonal Bank’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,931
| Closed | -$118K | – | 2648 |
|
|
2021
Q1 | $118K | Sell |
4,931
-4,036
| -45% | -$75K | ﹤0.01% | 2070 |
|
|
2020
Q4 | $131K | Buy |
8,967
+2,865
| +47% | +$38K | ﹤0.01% | 2090 |
|
|
2020
Q3 | $87K | Hold |
6,102
| – | – | ﹤0.01% | 2050 |
|
|
2020
Q2 | $90K | Buy |
6,102
+2,504
| +70% | +$25.4K | ﹤0.01% | 2002 |
|
|
2020
Q1 | $15K | Hold |
3,598
| – | – | ﹤0.01% | 2422 |
|
|
2019
Q4 | $17K | Hold |
3,598
| – | – | ﹤0.01% | 2532 |
|
|
2019
Q3 | $22K | Hold |
3,598
| – | – | ﹤0.01% | 2439 |
|
|
2019
Q2 | $23K | Hold |
3,598
| – | – | ﹤0.01% | 2440 |
|
|
2019
Q1 | $26K | Hold |
3,598
| – | – | ﹤0.01% | 2339 |
|
|
2018
Q4 | $17K | Hold |
3,598
| – | – | ﹤0.01% | 2488 |
|
|
2018
Q3 | $26K | Buy |
3,598
+2,367
| +192% | +$17.4K | ﹤0.01% | 2423 |
|
|
2018
Q2 | $8K | Hold |
1,231
| – | – | ﹤0.01% | 2511 |
|
|
2018
Q1 | $7K | Hold |
1,231
| – | – | ﹤0.01% | 2523 |
|
|
2017
Q4 | $5K | Hold |
1,231
| – | – | ﹤0.01% | 2534 |
|
|
2017
Q3 | $12K | Hold |
1,231
| – | – | ﹤0.01% | 2396 |
|
|
2017
Q2 | $15K | Hold |
1,231
| – | – | ﹤0.01% | 2344 |
|
|
2017
Q1 | $16K | Hold |
1,231
| – | – | ﹤0.01% | 2378 |
|
|
2016
Q4 | $15K | Hold |
1,231
| – | – | ﹤0.01% | 2361 |
|
|
2016
Q3 | $15K | Hold |
1,231
| – | – | ﹤0.01% | 2333 |
|
|
2016
Q2 | $11K | Hold |
1,231
| – | – | ﹤0.01% | 2360 |
|
|
2016
Q1 | $6K | Hold |
1,231
| – | – | ﹤0.01% | 2491 |
|
|
2015
Q4 | $10K | Hold |
1,231
| – | – | ﹤0.01% | 2397 |
|
|
2015
Q3 | $10K | Buy |
+1,231
| New | +$11.4K | ﹤0.01% | 2040 |
|
Zurich Cantonal Bank's GNMK Position: Q2 2021 in Review
Zurich Cantonal Bank sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 4,931 shares — an estimated $118K sold.
Zurich Cantonal Bank first reported a position in GNMK in Q3 2015 and held it in 23 quarters. The position peaked at $131K in Q4 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Zurich Cantonal Bank reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Zurich Cantonal Bank sold 4,931 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $118K.
- Zurich Cantonal Bank first reported a position in GenMark Diagnostics, Inc in Q3 2015 and held it in 23 quarters.
- Zurich Cantonal Bank's GenMark Diagnostics, Inc position peaked at $131K in Q4 2020.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Zurich Cantonal Bank's 13F filing for Q2 2021, filed 30 Jul 2021.